Canada markets close in 10 minutes

LAVA Therapeutics N.V. (LVTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.6700-0.0300 (-1.11%)
As of 03:49PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
6,769
6,769
19,391
5,350
3,747
Cost of Revenue
3,482
3,482
0
0
-
Gross Profit
3,287
3,287
19,391
5,350
-
Operating Expenses
Research Development
33,814
33,814
40,105
36,945
15,701
Selling General and Administrative
12,726
12,726
14,124
12,018
2,719
Total Operating Expenses
46,540
46,540
54,229
48,963
18,420
Operating Income or Loss
-43,253
-43,253
-34,838
-43,613
-14,673
Interest Expense
232
232
82
625
342
Total Other Income/Expenses Net
-1,412
-1,412
2,923
2,040
-869
Income Before Tax
-41,695
-41,695
-31,658
-42,198
-15,884
Income Tax Expense
279
279
249
157
43
Income from Continuing Operations
-41,974
-41,974
-31,907
-42,355
-15,927
Net Income
-41,974
-41,974
-31,907
-42,355
-15,927
Net Income available to common shareholders
-41,974
-41,974
-31,907
-42,355
-15,927
Basic EPS
-1.92
-1.57
-1.23
-2.14
-0.63
Diluted EPS
-1.92
-1.57
-1.23
-2.14
-0.63
Basic Average Shares
26,290
26,733
25,924
19,758
25,352
Diluted Average Shares
26,290
26,733
25,924
19,758
25,352